A Single Center, Two Part, Randomized, Open Label Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2017
At a glance
- Drugs GSK 525762 (Primary) ; Itraconazole; Rifampicin
- Indications Carcinoma; Haematological malignancies; Solid tumours
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 03 Mar 2017 Status changed from recruiting to completed.
- 25 Aug 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.
- 26 May 2016 Status changed from not yet recruiting to recruiting.